GIDCX
Price
$7.14
Change
-$0.13 (-1.79%)
Updated
Sep 6 closing price
VTIAX
Price
$32.84
Change
-$0.59 (-1.76%)
Updated
Sep 6 closing price
Ad is loading...

GIDCX vs VTIAX

Header iconGIDCX vs VTIAX Comparison
Open Charts GIDCX vs VTIAXBanner chart's image
Goldman Sachs Intl Eq Div & Prem C
Price$7.14
Change-$0.13 (-1.79%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index Admiral
Price$32.84
Change-$0.59 (-1.76%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GIDCX vs VTIAX Comparison Chart
Loading...
VS
GIDCX vs. VTIAX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GIDCX is a StrongSell and VTIAX is a StrongSell.

FUNDAMENTALS
Fundamentals
VTIAX has more cash in the bank: 453B vs. GIDCX (158M). VTIAX pays higher dividends than GIDCX: VTIAX (3.26) vs GIDCX (2.39). GIDCX was incepted earlier than VTIAX: GIDCX (17 years) vs VTIAX (14 years). GIDCX is a more actively managed with annual turnover of: 18.00 vs. VTIAX (4.00). GIDCX has a lower initial minimum investment than VTIAX: GIDCX (1000) vs VTIAX (3000). VTIAX (13.73) and GIDCX (13.35) have marching annual gain over last year. VTIAX return over 5 years is better than : 25.53 vs. GIDCX (21.50).
GIDCXVTIAXGIDCX / VTIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years14 years-
Gain YTD4.8567.71563%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets158M453B0%
Annual Yield % from dividends2.393.2673%
Returns for 1 year13.3513.7397%
Returns for 3 years5.54-4.58-121%
Returns for 5 years21.5025.5384%
Returns for 10 years10.4428.2437%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ORRF34.85-0.11
-0.31%
Orrstown Financial Services
DOW51.31-0.27
-0.52%
Dow
INDI3.84-0.06
-1.41%
indie Semiconductor
GKOS128.35-2.46
-1.88%
Glaukos Corp
XLO0.78-0.04
-4.83%
Xilio Therapeutics